FEN1-assisted LAMP for specific and multiplex detection of pathogens associated with community-acquired pneumonia

Guopeng Teng1, Gongde Lin2, Pengfan Wei1

  • 1Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Technology for Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350005, China. cqq036@fjmu.edu.cn.

The Analyst
|March 11, 2025
PubMed

Insights

A new flap endonuclease 1 (FEN1)-assisted loop-mediated isothermal amplification (LAMP) method offers rapid, multiplex detection of key community-acquired pneumonia (CAP) pathogens. This sensitive assay shows high consistency with PCR for clinical samples.

Area of Science:

  • Molecular Biology
  • Infectious Diseases
  • Biotechnology

Background:

  • Lower respiratory tract infections (LRITs), including community-acquired pneumonia (CAP), are a major global health concern.
  • Conventional diagnostic methods for LRIT pathogens are often slow, complex, and lack multiplexing capabilities.

Purpose of the Study:

  • To develop a novel, rapid, and multiplex diagnostic assay for common CAP pathogens.
  • To utilize flap endonuclease 1 (FEN1)-assisted loop-mediated isothermal amplification (LAMP) for enhanced detection.

Main Methods:

  • Designed a FEN1-assisted LAMP assay incorporating sequence-specific probes with flap structures.
  • Evaluated the assay's specificity, sensitivity, and limit of detection (100 copies/μL).
  • Validated the assay's performance against polymerase chain reaction (PCR) using clinical samples.

Main Results:

  • The FEN1-assisted LAMP assay demonstrated high specificity and sensitivity.
  • The assay successfully detected three leading CAP pathogens (Streptococcus pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae) in a single reaction.
  • Results showed high consistency with conventional PCR methods in clinical sample testing.

Conclusions:

  • FEN1-assisted LAMP provides a simple, specific, and multiplex method for detecting CAP pathogens.
  • This assay has significant potential for diagnosing CAP and could be adapted for other infectious agents.